MedPath

Adalat CC

ADALATCC ( nifedipine ) Extended Release Tablets For Oral Use

Approved
Approval ID

8d247bfb-8309-4cb8-847c-b4619a3d36d8

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

May 14, 2014

Manufacturers
FDA

Aphena Pharma Solutions - Tennessee, LLC

DUNS: 128385585

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

nifedipine

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code67544-185
Application NumberNDA020198
Product Classification
M
Marketing Category
C73594
G
Generic Name
nifedipine
Product Specifications
Route of AdministrationORAL
Effective DateMay 14, 2014
FDA Product Classification

INGREDIENTS (12)

NIFEDIPINEActive
Quantity: 90 mg in 1 1
Code: I9ZF7L6G2L
Classification: ACTIB
CELLULOSE, MICROCRYSTALLINEInactive
Code: OP1R32D61U
Classification: IACT
CROSPOVIDONEInactive
Code: 68401960MK
Classification: IACT
LACTOSEInactive
Code: J2B2A4N98G
Classification: IACT
HYDROXYPROPYL CELLULOSEInactive
Code: RFW2ET671P
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4
Classification: IACT
POLYETHYLENE GLYCOLSInactive
Code: 3WJQ0SDW1A
Classification: IACT
FERRIC OXIDE REDInactive
Code: 1K09F3G675
Classification: IACT
HYPROMELLOSESInactive
Code: 3NXW29V3WO
Classification: IACT
STARCH, CORNInactive
Code: O8232NY3SJ
Classification: IACT
TITANIUM DIOXIDEInactive
Code: 15FIX9V2JP
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Adalat CC - FDA Drug Approval Details